Valencell raises funds in hearables-biosensor deal with Sonion

June 18, 2018 //By Peter Clarke
Valencell raises funds in hearables-biosensor deal with Sonion
Sonion a/s (Roskilde, Denmark) a supplier of hearing aids and mobile hearable components has made a strategic investment biosensor developer Valencell Inc. (Rayleigh, North Carolina) as part of a $10.5 million Series E funding round.

Valencell was founded in 2006 and the investment from Sonion a/s and existing investors is intended to advance Valencells position in biometric sensors for hearables and wearables. TDF Ventures, GII LLC, and WSJ Joshua Fund participated in the funding.

This brings the total amount of funding raised to date to $35 million.

Sonion and Valencell have a strategic partnership to make biometrics universal in the hearables and hearing health markets.

The market for wearable biometric sensors continues to rapidly expand beyond traditional consumer wearables devices, particularly in health and medical devices, military and industrial safety, and AR/VR devices and use cases.

"With Sonion leading the investment round, Valencell gains a powerful strategic partner to bring new capabilities to serve the consumer hearables and hearing health markets," said Michael Dering, CEO of Valencell, in a statement.

Related links and articles:

News articles:

ST, Valencell offer biometric sensor platform dev kit

Vital signs sensor could transform smartphones

InvenSense, Sonion launch miniature MEMS microphones

Vous êtes certain ?

Si vous désactivez les cookies, vous ne pouvez plus naviguer sur le site.

Vous allez être rediriger vers Google.